Hatch-Waxman

14

Patents

8

Pharmaceutical

7

Generic Drugs

5

ANDA

5

FTC

4

Infringement

4

SCOTUS

3

America Invents Act

3

Pay-For-Delay

3

Reverse Payment Settlement Agreements

3

Safe Harbors

2

Anti-Competitive

2

Cephalon

2

FDA

2

Prescription Drugs

2

Reverse Payments

2

Settlement

2

Watson Pharmaceuticals

1

Actavis Inc.

1

Allergan Inc

1

AstraZeneca

1

Biofuel

1

Biogen Idec

1

Biotechnology

1

Brand

1

Classen Immunotherapies

1

Clear and Convincing Evidence

1

Combination Products

1

Crestor

1

Design Patent

1

Discovery

1

Doctrine of Equivalents

1

Drug Manufacturers

1

eBay

1

Exemptions

1

Expert Testimony

1

GlaxoSmithKline

1

Injunctions

1

Integra

1

Inter Partes Review Proceedings

1

InterDigital Communications v ITC

1

Joinder

1

Manufacturers

1

Mayo v. Prometheus

1

Merck

1

Mylan Pharmaceuticals

1

Non-Practicing Entities

1

Nonobviousness

1

Par/Paddock

1

Patent Litigation

1

Preliminary Injunctions

1

Premarket Approval Applications

1

Presumption of Validity

1

Prioritized Examination

1

Reissue Patents

1

Restraint of Trade

1

Reversal

1

Rosuvastatin

1

Sales Contracts

1

Standard of Proof

1

Standard of Review

1

Supplemental Examination

1

Vitiation Test